Min Chen
About Min Chen
Min Chen is a Senior Research Investigator at Bristol Myers Squibb in the United States, with a background in pharmaceutical sciences and extensive experience in pharmacometrics and translational medicine.
Current Role at Bristol Myers Squibb
Min Chen currently serves as a Senior Research Investigator at Bristol Myers Squibb in the United States. In this role, she engages in cutting-edge research across multiple therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. She utilizes advanced data analytics and pharmacometrics to optimize clinical trial designs, integrating these methodologies into the drug development pipeline.
Educational Background
Min Chen achieved her Doctor of Philosophy (PhD) in Pharmaceutical Sciences from The Ohio State University, where she studied from 2017 to 2021. She also holds a Bachelor of Science (BS) in Biotechnology from Nanjing Agricultural University. Her academic background has provided a strong foundation for her research interests and professional endeavors in pharmacokinetics and pharmacodynamics.
Previous Positions and Experience
Prior to her current role, Min Chen worked at Novartis Institutes for BioMedical Research (NIBR) as a Summer Intern in Clinical PBPK (Pharmacokinetics and Pharmacodynamics Modeling and Simulation) in 2021. From 2017 to 2021, she was a Graduate Research Associate at The Ohio State University College of Pharmacy. Before that, she spent six years at WuXi AppTec as a DMPK (Drug Metabolism and Pharmacokinetics) Study Director, overseeing a range of studies.
Published Research and Presentations
Min Chen has published numerous research papers on pharmacokinetics and pharmacodynamics in peer-reviewed journals. Additionally, she has presented her findings at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) annual meetings. Her novel PBPK model has been adopted in clinical trial simulations, contributing to advancements in the field.
Awards and Recognitions
Min Chen's work has been recognized with the Best Poster Award at the International Conference on Pharmacometrics. Her contributions to the field of pharmacometrics and drug development have earned her recognition from her peers and established her as a thought leader in the industry.